Company Profile for Mirum Pharmaceuticals

September 26, 2019 Off By BusinessWire

–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).

Company:

Mirum Pharmaceuticals

 

 

Headquarters Address:

950 Tower Lane

 

Suite 1050

 

Foster City, CA 94404

 

 

Main Telephone:

650-667-4085

 

 

Website:

www.mirumpharma.com

 

 

Ticker:

MIRM(NASDAQ)

 

 

Type of Organization:

Public

 

 

Industry:

Biotechnology

 

 

Key Executives:

CFO: Ian Clements

 

 

Investor Relations

 

Contact:

Ian Clements

Email:

[email protected]